Ali F Madhloom
Research Subjects
Research Interests
Ali F Madhloom has a total of 2 co-authors. Here are the top co-authors by number of shared publications:
- Firas Bashir Al-Taweel
Department of Periodontics College of Dentistry University of Baghdad Baghdad Iraq
1 shared publication - Omar H Soliman1 shared publication
Latest Publications
- Open Access
- 15 December 2025
- Published by Journal of Baghdad College of Dentistry in Journal of Baghdad College of Dentistry
- Vol. 37 (4) , 36-50
Determining the antibacterial efficacy of Amoxicillin-Clavulanic acid (Augmentin®), Metronidazole and Ethanolic extract of Moringa oleifera L. against clinically isolated Porphyromonas gingivalis (in vitro study)
Background: Amoxicillin-clavulanic acid (Augmentin®), Metronidazole, Amoxil/Metro combination, and Azithromycin are commonly utilized as adjunctive treatment of periodontitis. Moringa oleifera L (Mo) leaves extracts have demonstrated the ability to inhibit the growth of facultative anaerobic bacteria including Porphyromonas. gingivalis (P. gingivalis), Escherichia coli, Pseudomonas aeruginosa, Bacillus cereus, Shigella sonnei, Staphylococcus aureus, Bacillus subtilis, Beta-hemolytic streptococcus, Bacillus megaterium as well as dental biofilm development. Objectives: The present study was set out to determine the antibacterial efficacy of Amoxicillin-clavulanic acid (Augmentin®), Metronidazole and Ethanolic extract of Mo leaves against P. gingivalis clinical isolate. Materials and Methods: The minimum inhibition concentrations (MIC), minimum bactericidal concentrations (MBC), and sensitivity of the clinical isolated P. gingivalis against Mo ethanolic leaves extracts, Augmentin, and Metronidazole were determined using two-fold serial dilution, agar well diffusion, and disk diffusion, respectively. The gas chromatography–mass spectrometry (GC-MS) was used for phytochemical analysis of the Mo leaves extract using ethanol solvent. Results: P. gingivalis exhibited inhibition to Mo leaves extract, while it demonstrated resistance to Augmentin and Metronidazole. MIC and MBC of Mo leaves extract were found to be 0.78 mg/ml and 1.56 mg/ml against P. gingivalis, respectively. The extract had highest anti-biofilm effect at the minimum concentrations of 1.55 mg/ml and 0.78 mg/ml equivalent to 0.06% Chlorhexidine compared to its lowest conc at 0.34 mg/ml, and this activity was inversely proportional to the extract’s concentration. Conclusion: While Augmentin and Metronidazole showed no sensitivity against P. gingivalis, the promising antibacterial effect of Mo leaves extract against this bacterium may indicates its potential for use in oral health promotion, suggesting further in vivo studies to validate Mo extracts as alternative adjuncts in periodontitis therapy.
- 15 December 2025
- Published by Journal of Baghdad College of Dentistry in Journal of Baghdad College of Dentistry
- Vol. 37 (4) , 36-50
Open AccessDetermining the antibacterial efficacy of Amoxicillin-Clavulanic acid (Augmentin®), Metronidazole and Ethanolic extract of Moringa oleifera L. against clinically isolated Porphyromonas gingivalis (in vitro study)
Background: Amoxicillin-clavulanic acid (Augmentin®), Metronidazole, Amoxil/Metro combination, and Azithromycin are commonly utilized as adjunctive treatment of periodontitis. Moringa oleifera L (Mo) leaves extracts have demonstrated the ability to inhibit the growth of facultative anaerobic bacteria including Porphyromonas. gingivalis (P. gingivalis), Escherichia coli, Pseudomonas aeruginosa, Bacillus cereus, Shigella sonnei, Staphylococcus aureus, Bacillus subtilis, Beta-hemolytic streptococcus, Bacillus megaterium as well as dental biofilm development. Objectives: The present study was set out to determine the antibacterial efficacy of Amoxicillin-clavulanic acid (Augmentin®), Metronidazole and Ethanolic extract of Mo leaves against P. gingivalis clinical isolate. Materials and Methods: The minimum inhibition concentrations (MIC), minimum bactericidal concentrations (MBC), and sensitivity of the clinical isolated P. gingivalis against Mo ethanolic leaves extracts, Augmentin, and Metronidazole were determined using two-fold serial dilution, agar well diffusion, and disk diffusion, respectively. The gas chromatography–mass spectrometry (GC-MS) was used for phytochemical analysis of the Mo leaves extract using ethanol solvent. Results: P. gingivalis exhibited inhibition to Mo leaves extract, while it demonstrated resistance to Augmentin and Metronidazole. MIC and MBC of Mo leaves extract were found to be 0.78 mg/ml and 1.56 mg/ml against P. gingivalis, respectively. The extract had highest anti-biofilm effect at the minimum concentrations of 1.55 mg/ml and 0.78 mg/ml equivalent to 0.06% Chlorhexidine compared to its lowest conc at 0.34 mg/ml, and this activity was inversely proportional to the extract’s concentration. Conclusion: While Augmentin and Metronidazole showed no sensitivity against P. gingivalis, the promising antibacterial effect of Mo leaves extract against this bacterium may indicates its potential for use in oral health promotion, suggesting further in vivo studies to validate Mo extracts as alternative adjuncts in periodontitis therapy.